medigraphic.com
SPANISH

Biotecnología Aplicada

ISSN 1027-2852 (Electronic)
ISSN 0864-4551 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 3

<< Back

Biotecnol Apl 2012; 29 (3)

Genetic characterization of Pneumocystis jirovecii in patients dying of AIDS, IPK, 1995-2008

de Armas Y, Capó V, Govín A, López LX, Friaza V, Durand-Joly I, de la Horra C, Dei-Cas E, Calderón E
Full text How to cite this article

Language: Spanish
References: 8
Page: 198-199
PDF size: 89.09 Kb.


Key words:

Pneumocystis/i>, genetic characterization, resistance.

ABSTRACT

Pneumocystis jirovecii is a frequent opportunistic pathogen in HIV/AIDS. The inability to culture this species prevents from acquiring deeper knowledge about its biology, drug susceptibility as well as the epidemiology of the disease that it produces. Pneumocystosis diagnosis in Cuba is suspected, based on the clinical and radiological findings which often lead to misdiagnosis since other microorganisms produce symptoms, signs and radiological patterns similar to this infection. Currently, the status on drug resistance is unknown and there are no means to evaluate the resistance to the recommended drugs. On the other hand, no studies on the distribution of P. jirovecii of genotypes in the country have been described. The results of the present study allows: a) to describe for the first time in the literature a new genotype of mitochondrial small RNA ribosomal subunit (160A/196T), b) to suggest a narrow circulation of the pathogen in Cuba; and c) to assume a very low prevalence of sulfamide resistance linked to mutations of P. jirovecii in our country. The results obtained constitute highly valuable knowledge of pneumocystosis in Cuba, as well as worldwide since they provide new information that can be used to a better disease management.


REFERENCES

  1. Calderon EJ, Gutierrez-Rivero S, Durand-Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev Anti Infect Ther. 2010;8(6):683-701.

  2. de Armas Rodriguez Y, Wissmann G, Muller AL, Pederiva MA, Brum MC, Brackmann RL, et al. Pneumocystis jirovecii pneumonia in developing countries. Parasite. 2011;18(3):219-28.

  3. Rodríguez-Vigil E. Neumonía intersticial por Pneumocystis carinii. Rev Cubana Pediatr. 1969;41:317.

  4. Razón Behar R, Cubero Menéndez O, Vázquez Rios B, Chao Barreiro A, Gala Valiente M, Cubeñas Chala YD. Pneumocystis carinii pneumonia. Rev Cubana Med Trop. 1977;29(3):103-14.

  5. Menendez Capote R, Millan Marcelo JC. [Infections and other opportunistic processes in a group of Cuban stage-IV HIV patients]. Rev Cubana Med Trop. 1992; 44(1):47-9.

  6. Arteaga Hernandez E, Capo de Paz V, Perez Fernandez-Teran ML. Micosis oportunistas invasivas en el sida. Un estudio de 211 autopsias. Rev Iberoam Micol. 1998;15(1):33-5.

  7. de Armas Y, Capó V, López Fuentes L. Detección molecular de Pneumocystis jiroveci en tejido parafinado de fallecidos por VIH/sida. Rev Cubana Med Trop. 2008 [cited 2012 May 17];60(3):[about 7 p.]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602008000300009&lng=en&nrm= iso&tlng=es.

  8. de Armas Y, Friaza V, Capo V, Durand-Joly I, Govin A, de la Horra C, et al. Low genetic diversity of Pneumocystis jirovecii among Cuban population based on two-locus mitochondrial typing. Med Mycol. 2012;50(4):417-20.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Biotecnol Apl. 2012;29